DeutschNewstral
Article
newatlas.com on 2024-04-25 02:00
Anti-aging biopharma company raises $40 million to begin human tests
Related news
Gaithersburg biopharma raises another $11Mbizjournals.com- First phase of human trials begin for experimental coronavirus vaccinenewatlas.com
- Houston-based Kiromic BioPharma shares begin tradingbizjournals.com
- Anti-aging stem cell treatment proves successful in early human trialsnewatlas.com
- Gaithersburg biopharma company Sirnaomics raises $25Mbizjournals.com
- Main Line biopharma firm raises $25 millionbizjournals.com
- Biopharma startup Triumvira Immunologics raises $55Mbizjournals.com
- Vor Biopharma raises $177M in upsized IPObizjournals.com
- Experimental cancer vaccine passes animal tests, moves to human trialsnewatlas.com
Japan startup to begin human clinical tests for COVID-19 drug in 2021The Japan Times- BPfizer and BioNTech Begin U.S. Human Trial of a Covid-19 Vaccinebarrons.com
Johnson & Johnson ramps up production of affordable Covid-19 vaccine, human trials to begin soonherald.co.zw- Local biopharma Ascentage Pharma raises $150M for cancer drug pipelinebizjournals.com
- Berwyn biopharma firm focused on inflammatory diseases raises $11Mbizjournals.com
- FMedicxi raises €400m as Europe warms up to biopharmaft.com
- GIsraeli biopharma Mileutis raises $20M to save the dairy industrygeektime.com
- Baltimore biopharma targeting eye diseases raises $5 millionbizjournals.com
- PureTech’s Vor Biopharma raises $42M for blood cancer drugsbizjournals.com
Pfizer Raises Earnings Projections on Biopharma Sales Increasewsj.com- Pharmacy college raises $3.25M and renames biopharma training centerbizjournals.com